369 related articles for article (PubMed ID: 5353469)
21. [Interaction of sydnocarb with preparations influencing the metabolism of catecholamines].
Al'tshuler RA; Roshchina LF; Mashkovskiĭ MD
Farmakol Toksikol; 1976; 39(1):9-14. PubMed ID: 943326
[TBL] [Abstract][Full Text] [Related]
22. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
Hutchins DA; Rogers KJ
Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
[TBL] [Abstract][Full Text] [Related]
23. Effects of inhibitors of the catecholamine synthesis on motor activity in the rat during light and darkness.
Berger T; Lemmer B
Pol J Pharmacol Pharm; 1976; 28(6):601-3. PubMed ID: 1012983
[TBL] [Abstract][Full Text] [Related]
24. Effects of guancydine on catecholamine synthesis storage and catabolism.
Ellenbogen L; Chan PS; Cummings JF
Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):170-9. PubMed ID: 4856856
[No Abstract] [Full Text] [Related]
25. Catecholamines and drug-behavior interactions.
Seiden LS; MacPhail RC; Oglesby MW
Fed Proc; 1975 Aug; 34(9):1823-31. PubMed ID: 1097267
[TBL] [Abstract][Full Text] [Related]
26. Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.
Cooper BR; Breese GR
Adv Biochem Psychopharmacol; 1974; 12(0):353-68. PubMed ID: 4609223
[No Abstract] [Full Text] [Related]
27. Effect of carbaryl on catecholamines in brain regions.
Ray SK; Haque SJ; Poddar MK
Indian J Exp Biol; 1984 Mar; 22(3):141-4. PubMed ID: 6440860
[No Abstract] [Full Text] [Related]
28. [The action of 2-amino-4-(isothioureyl methyl)-thiazol dihydrochloride (Agr 307) on the catecholamines of the central nervous system in the rat. Possible inhibition of dopamine beta-hydroxylase].
Brunaud M; Vallée E; Laborit H
Agressologie; 1971; 12(2):113-8. PubMed ID: 5123844
[No Abstract] [Full Text] [Related]
29. New developments in brain chemistry: catecholamine metabolism and the action of psychotropic drugs.
Snyder SH
Am J Orthopsychiatry; 1967 Oct; 37(5):864-79. PubMed ID: 4861482
[No Abstract] [Full Text] [Related]
30. Behavior and brain contents of catecholamines in mice during chronic administration of methyldopa.
Dominic JA; Moore KE
Neuropharmacology; 1971 Sep; 10(5):565-70. PubMed ID: 4399541
[No Abstract] [Full Text] [Related]
31. On the functional role of pre- and postsynaptic catecholamine receptors in brain.
Strömbom U
Acta Physiol Scand Suppl; 1975; 431():1-43. PubMed ID: 181950
[No Abstract] [Full Text] [Related]
32. A comparative study of the influence of 6-hydroxydopamine, alpha methyltyrosine and 5,6-dihydroxy-tryptamine, p-chlorophenylalanine on the open field behaviour of rats.
Kulkarni SK; Dandiya PC; Jain KM
Indian J Physiol Pharmacol; 1974; 18(4):324-9. PubMed ID: 4282853
[No Abstract] [Full Text] [Related]
33. A developmental role for catecholamines in Drosophila behavior.
Pendleton RG; Rasheed A; Paluru P; Joyner J; Jerome N; Meyers RD; Hillman R
Pharmacol Biochem Behav; 2005 Aug; 81(4):849-53. PubMed ID: 16051344
[TBL] [Abstract][Full Text] [Related]
34. Proceedings: Pharmacology of the adrenergic mechanism.
Pfeifer AK
J Neural Transm; 1974; Suppl 11(0):163-80. PubMed ID: 4135935
[No Abstract] [Full Text] [Related]
35. A comparison of the effects of d-amphetamine and morphine upon the locomotor activity of mice treated with drugs which alter brain catecholamine content.
Villarreal JE; Guzman M; Smith CB
J Pharmacol Exp Ther; 1973 Oct; 187(1):1-7. PubMed ID: 4746328
[No Abstract] [Full Text] [Related]
36. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
Segal DS; McAllister C; Geyer MA
Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
[No Abstract] [Full Text] [Related]
37. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.
Martin-Iverson MT; Yamada N; By AW; Lodge BA
J Psychiatry Neurosci; 1991 Dec; 16(5):253-61. PubMed ID: 1686728
[TBL] [Abstract][Full Text] [Related]
38. Affective disorders and norepinephrine pharmacology.
Schildkraut JJ; Schanberg SM; Kopin IJ; Durell J
Int Psychiatry Clin; 1969; 6(2):83-141. PubMed ID: 4897536
[No Abstract] [Full Text] [Related]
39. Comparative studies of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain.
Scheel-Krüger J
Eur J Pharmacol; 1971; 14(1):47-59. PubMed ID: 4396660
[No Abstract] [Full Text] [Related]
40. Stimulus-dependent antagonism of the alpha-methyltyrosine-induced lowering of brain catecholamines by (+)-amphetamine in intact mice.
Welch BL; Welch AS
J Pharm Pharmacol; 1967 Dec; 19(12):841-3. PubMed ID: 4384230
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
